Bruce Guzowski is joining DMCG Holding Corporation as chief executive. The company is a portfolio company of High Road Capital Partners, and is a provider of promotional medical education communication services to the pharmaceutical and biotechnology industries. The company operates through two subsidiaries: Dowden Medical Communications Group and QD Healthcare Group. Guzowski was previously the president and CEO of Boston-based HCPro Inc.
High Road Capital Partners (www.highroadcap.com) is pleased to announce that it has appointed Bruce Guzowski as Chief Executive Officer of its portfolio company DMCG Holding Corporation (DMCG). DMCG is a leading provider of promotional medical education communication services, scientific content development, and related marketing services to the pharmaceutical and biotechnology industries through its two subsidiaries, Dowden Medical Communications Group and QD Healthcare Group.
Until 2009, Mr. Guzowski was the President and CEO of Boston-based HCPro, Inc., the country’s largest provider of information, educational, and advisory products and services in the areas of compliance, regulation, and management to the U.S. healthcare industry. Mr. Guzowski partnered with members of the High Road team to acquire HCPro in a highly successful management buy-out. Since his departure from HCPro, Mr. Guzowski has served on several boards of directors and as an advisor to several private-equity backed media, healthcare service and marketing-service companies.
“All the Partners at High Road have worked with Bruce in the past and we are delighted to bring his leadership, strategy and ability to grow businesses to DMCG,” said Jeffrey Goodrich, a High Road Partner. Robert Fitzsimmons, High Road’s Managing Partner added, “Bruce’s experience in successfully sourcing, completing and integrating over 20 acquisitions at HCPro will be invaluable as DMCG grows through add-on acquisitions.”
Mr. Guzowski will chair the DMCG Executive Committee which includes Jim Hughes, President of Dowden Medical Communications Group, and Nick Kiratsous, President of QD Healthcare Group.
For further information, please contact Jeffrey Goodrich at (212) 554-3268.
High Road Capital Partners
High Road Capital Partners is a private equity firm focused on smaller middle market transactions. High Road was formed in 2007 and currently manages over $150 million of committed capital. High Road focuses on niche-leading companies with revenues of $10 million to $100 million and EBITDA of $3 million to $10 million. Once acquired, High Road works in partnership with management to take the companies to the next level through a combination of organic growth initiatives and add-on acquisitions. High Road has completed 22 transactions, including 20 acquisitions – nine platform investments and 11 add-on acquisitions – for its debut fund, High Road Capital Partners Fund I, LP. More information on High Road may be found on its website, www.highroadcap.com.
Dowden Medical Communications Group
Dowden Medical Communications Group is a provider of promotional medical education communication services through Medical Decision Point, LLC and Convergent Health Solutions, LLC; and eCrossings Media. DMCG is headquartered in Montvale, New Jersey. Further information about DMCG is available at www.convergent-health.com, www.medicaldecisionpoint.com and www.ecrossingsmedia.com.
QD Healthcare Group
QD Healthcare Group provides scientific content development, promotional medical education and related marketing services to the pharmaceutical and biotechnology industries. QD Healthcare Group is located in Stamford, Connecticut.